Conigliaro R, Rossi A
Department of Digestive Endoscopy, ASMN, Reggio Emilia, Italy.
Endoscopy. 2006 Nov;38(11):1137-43. doi: 10.1055/s-2006-944842.
Following publication in 2000 of the Italian Guidelines for Sedation in Digestive Endoscopy, the authors carried out a dissemination program and an audit of the impact of the Guidelines in clinical practice. The primary aim was to evaluate any changes in sedation methods at the start of and during the study period (at 0, 6, and 12 months). Secondary study aims were detailed analyses of endoscopies regarding sedation, complications, and patient satisfaction.
The prospective, observational, multicenter study was commenced in 60 centers (31 first- and 29 second-level) which opted to have seminars on the Guidelines; results concerning sedation practices in relation to endoscopic procedure, complications, and patient satisfaction were recorded at the start of the study (phase 0) and at 6 and 12 months. Over a 1-year period, 5261 sedated and unsedated patients undergoing endoscopic procedures were enrolled (with data collection between December 1999 and June 2002). The results were analyzed using the chi-squared test.
Data were available for all three assessment time points from 29 of the 60 centers. The sedation rate, between phase 0 and 2, increased by 12.75% in first-level centers and 0.73% in second-level centers with midazolam use increasing from 34% to 41%. For colonoscopy, sedation usage increased from 52% to 56%. Adverse events occurred in 0.47% of the patients, without long-term sequelae or death, and patient satisfaction was only slightly, but not significantly higher with sedation (90.4% of sedated patients were "very satisfied" vs. 87% of unsedated patients who were "satisfied"), but the examination was more likely to be complete in sedated patients and this difference was statistically significant ( P < 0.001).
We conclude that if sedation is used as recommended by the Guidelines, it is possible to control clinical risk by using high quality endoscopic procedures.
2000年意大利消化内镜镇静指南发布后,作者开展了一项传播计划并对该指南在临床实践中的影响进行了审核。主要目的是评估研究期间开始时及研究过程中(0、6和12个月)镇静方法的任何变化。次要研究目的是对内镜检查在镇静、并发症和患者满意度方面进行详细分析。
这项前瞻性、观察性、多中心研究在60个中心(31个一级中心和29个二级中心)开展,这些中心选择参加关于该指南的研讨会;在研究开始时(0阶段)以及6个月和12个月时记录与内镜检查操作、并发症和患者满意度相关的镇静实践结果。在1年时间里,纳入了5261例接受内镜检查的镇静和未镇静患者(数据收集时间为1999年12月至2002年6月)。使用卡方检验对结果进行分析。
60个中心中的29个中心在所有三个评估时间点均有数据。在一级中心,0阶段至2阶段的镇静率增加了12.75%,二级中心增加了0.73%,咪达唑仑的使用从34%增加到41%。对于结肠镜检查,镇静使用率从52%增加到56%。0.47%的患者发生了不良事件,无长期后遗症或死亡情况,镇静患者的满意度仅略有提高,但差异无统计学意义(90.4%的镇静患者“非常满意”,而未镇静患者中87%“满意”),但镇静患者的检查更有可能完成,且这种差异具有统计学意义(P<0.001)。
我们得出结论,如果按照指南推荐使用镇静,通过采用高质量的内镜检查操作可以控制临床风险。